Viewing StudyNCT04641442



Ignite Creation Date: 2024-05-06 @ 3:29 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04641442
Status: RECRUITING
Last Update Posted: 2024-06-25
First Post: 2020-11-20

Brief Title: Study to Evaluate the Efficacy Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases Including NLRC4-GOF XIAP Deficiency or CDC42 Mutations
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
NLRC4-GOF AIFEC Autoinflammation With Infantile Enterocolitis XIAP Deficiency CDC42 Mutations
Keywords:
Name View
NLRC4-GOF View
AIFEC View
enterocolitis View
autoinflammation View
MAS View
NLRC4 SCAN4 View
XIAP deficiency View
CDC42 mutations View